Both in Pharmaceuticals
Standard BioTools vs Korro Bio
Over the past year LAB returned −50.8% and KRRO returned −57.0%; their daily moves had a correlation of 0.03.
LAB −50.8% KRRO −57.0%Growth of $1, one year, split-adjusted
| Metric | LAB | KRRO |
|---|---|---|
| Price | $0.6099 | $15.85 |
| Market cap | $240.7M | $233.3M |
| Today | −0.02% | +10.69% |
| 1 month | −18.1% | +64.4% |
| 6 months | −34.8% | +21.6% |
| Year to date | −52.4% | +97.8% |
| 1 year | −47.0% | −56.5% |
| Revenue growth (YoY) | −7.6% | −100.0% |
| Gross margin | 52.4% | — |
| Net margin | −133.1% | — |
| P/E (TTM) | 2.8× | — |
| Price / sales | 2.8× | 98.0× |
| Net cash | $476.4M | $115.0M |
| Dividend yield | — | — |
| Volatility (60d) | 45.5% | 95.8% |
| Short % of float | 1.1% | 14.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).